Description
This peptide is an epitope of carcinoembryonic antigen and is recognized by T cells in the immune system; it may have potential in the development of vaccines or targeting therapies.
Product Unit Size | Cost | Quantity | Stock |
---|
This peptide is an epitope of carcinoembryonic antigen and is recognized by T cells in the immune system; it may have potential in the development of vaccines or targeting therapies.
Purity | ≥95% |
---|---|
Formula | C43H69N11O14 |
Formula Wt. | 964.09 |
Synonym | CEA (605-613) |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Hou Y, Kavanagh B, Fong L. Distinct CD8+ T cell repertoires primed with agonist and native peptides derived from a tumor-associated antigen. J Immunol. 2008 Feb 1;180(3):1526-34. PMID: 18209048.
Tosi D, Valenti R, Cova A, et al. Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens. J Immunol. 2004 May 1;172(9):5363-70. PMID: 15100276.
Produced by various marine proteobacteria
CDK4/6 inhibitor.
Steroid; AR antagonist.
γ-Secretase inhibitor.
Chloroethylnitrosourea, DNA alkylator and cross...
MEK1/2 inhibitor.
Dithiolopyrrolone; RNA polymerase inhibitor.
JAK2 inhibitor
Synthetic ITC.
Antipruritic.
Polyphenol found in various plants and foods.
Endogenous peptide, cleavage product of AT II; ...
ATP competitive CDK inhibitor.
Mineralocorticoid antagonist.
Effective against gram-positive pathogens
ALK, c-Fes, LRRK2 inhibitor.
Diterpenoid epoxide found in Tripterygium.
Endogenous neurotransmitter; GABA agonist.
Endogenous APP peptide cleavage product, primar...
KRAS inhibitor